3D engineered cardiac tissue models of human heart disease: Learning more from our mice

Trends in Cardiovascular Medicine

Volumn 23, Issue 2, 2013, Pages 27-32

  Ralphe, J Carter ^a   De Lange, Willem J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNEXIN 43; FIBRINOGEN; ISOPRENALINE; MATRIGEL; MYOSIN BINDING PROTEIN C;

ACTION POTENTIAL; ADRENERGIC STIMULATION; BLOOD VESSEL GRAFT; CHRONOTROPISM; CONTACT INHIBITION; DISEASE MODEL; EMBRYONIC STEM CELL; ENVIRONMENTAL STRESS; EXTRACELLULAR MATRIX; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FIBROBLAST; FORCE TRANSDUCER; GAP JUNCTION; GENETIC HETEROGENEITY; GENETIC MANIPULATION; GENOTYPE PHENOTYPE CORRELATION; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PACING; HEART PAPILLARY MUSCLE; HUMAN; INOTROPISM; ISOLATED HEART; MACROPHAGE; MONOLAYER CULTURE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; TREATMENT RESPONSE;

ANIMALS; DISEASE MODELS, ANIMAL; HEART; HEART DISEASES; HUMANS; IMAGING, THREE-DIMENSIONAL; MICE; TISSUE ENGINEERING;

EID: 84873145613     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.08.007     Document Type: Review

References (19)

1. Akins R.E., Rockwood D., Robinson K.G., Sandusky D., Rabolt J., Pizarro C. Three-dimensional culture alters primary cardiac cell phenotype. Tissue Engineering Part A 2010, 16:629-641.
2. Bell R.M., Mocanu M.M., Yellon D.M. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. Journal of Molecular and Cellular Cardiology 2011, 50:940-950.
3. Chu G., Haghighi K., Kranias E.G. From mouse to man: understanding heart failure through genetically altered mouse models. Journal of Cardiac Failure 2002, 8:S432-S449.
4. de Lange W.J., Hegge L.F., Grimes A.C., et al. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circulation Research 2011, 109:8-19.
5. Eschenhagen T., Fink C., Remmers U., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB Journal 1997, 11:683-694.
6. Fujimoto K.L., Clause K.C., Liu L.J., et al. Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Engineering Part A 2011, 17:585-596.
7. Hansen A., Eder A., Bonstrup M., et al. Development of a drug screening platform based on engineered heart tissue. Circulation Research 2010, 107:35-44.
8. Kira Y., Nakaoka T., Hashimoto E., Okabe F., Asano S., Sekine I. Effect of long-term cyclic mechanical load on protein synthesis and morphological changes in cultured myocardial cells from neonatal rat. Cardiovascular Drugs and Therapy 1994, 8:251-262.
9. Louch W.E., Sheehan K.A., Wolska B.M. Methods in cardiomyocyte isolation, culture, and gene transfer. Journal of Molecular and Cellular Cardiology 2011, 51:288-298.
10. Nistri S., Pini A., Sassoli C., et al. Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration. Journal of Cellular and Molecular Medicine 2012, 16:507-519.
11. O'Connell T.D., Rodrigo M.C., Simpson P.C. Isolation and culture of adult mouse cardiac myocytes. Methods in Molecular Biology 2007, 357:271-296.
12. Ou D.-B., He Y., Chen R., et al. Three-dimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. Journal of Cellular Biochemistry 2011, 112:3555-3562.
13. Patterson J.T., Gilliland T., Maxfield M.W., et al. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again. Regenerative Medicine 2012, 7:409-419.
14. Schaaf S., Shibamiya A., Mewe M., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6:e26397.
15. Tobita K., Liu L.J., Janczewski A.M., et al. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. American Journal of Physiology Heart and Circulatory Physiology 2006, 291:H1829-H1837.
16. Tulloch N.L., Muskheli V., Razumova M.V., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circulation Research 2011, 109:47-59.
17. Xi J., Khalil M., Shishechian N., et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB Journal 2010, 24:2739-2751.
18. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnology and Bioengineering 2000, 68:106-114.
19. Zimmermann W.H., Melnychenko I., Wasmeier G., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine 2006, 12:452-458.